| Literature DB >> 30306833 |
Abstract
Impairment caused by Amyotrophic lateral sclerosis (ALS) is multidimensional (e.g. bulbar, fine motor, gross motor) and progressive. Its multidimensional nature precludes a single outcome to measure disease progression. Clinical trials of ALS use multiple longitudinal outcomes to assess the treatment effects on overall improvement. A terminal event such as death or dropout can stop the follow-up process. Moreover, the time to the terminal event may be dependent on the multivariate longitudinal measurements. In this article, we develop a joint model consisting of a multidimensional latent trait linear mixed model (MLTLMM) for the multiple longitudinal outcomes, and a proportional hazards model with piecewise constant baseline hazard for the event time data. Shared random effects are used to link together two models. The model inference is conducted using a Bayesian framework via Markov chain Monte Carlo simulation implemented in Stan language. Our proposed model is evaluated by simulation studies and is applied to the Ceftriaxone study, a motivating clinical trial assessing the effect of ceftriaxone on ALS patients.Entities:
Keywords: Amyotrophic lateral sclerosis; Markov chain Monte Carlo; informative dropout; longitudinal data; mixed model
Mesh:
Substances:
Year: 2018 PMID: 30306833 PMCID: PMC6478574 DOI: 10.1177/0962280218802300
Source DB: PubMed Journal: Stat Methods Med Res ISSN: 0962-2802 Impact factor: 3.021